ODAIA
ODAIA provides an AI-driven commercial analytics platform for pharmaceutical companies, using predictive modeling and customer journey data to help sales, marketing, and access teams prioritize healthcare providers and optimize omnichannel engagement. The company sells its software on a subscription basis to life sciences organizations seeking to improve field force productivity and brand performance.
- Product Analytics & Feedback
- Business Intelligence & Dashboards
- Data Integration & ETL
- Revenue
- $9.0M
- Employees
- 85
- Founded
- 2018
- Headquarters
- Toronto, Canada
What 6 Arbolus experts think of ODAIA
NPS scores among ODAIA customers range from 5 to 9, with 67% of users reporting an NPS of 7 or above. Renewal intent is not disclosed, but stickiness is high: 67% of customers have used ODAIA for over a year, suggesting entrenched value. Users in pilot or early stages still provide moderate-to-high NPS scores. Sentiment is thus moderately positive, primarily concentrated within enterprise pharma user groups.Positive
Who reviewed ODAIA
- C-Suite 67% (4)
- Director 33% (2)
Employer names and spend open once the report publishes.
Tell us when the ODAIA report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
16 Net Promoter Score, from 6 scored reviews- Promoters 2
- Passives 3
- Detractors 1
Written answers and themes publish with the full report.
More in Data & Analytics and Marketing & Advertising
Other companies in both categories with a customer report.
For people who use ODAIA
Do you use ODAIA at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 6 customers of ODAIA have already contributed
Takes a few minutes. Your identity stays anonymous.